Psychiatry & Neurology Doctors in Indiana, PA Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Dr. Randeep C Hayer, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 793 Old Route 119 Hwy N, Indiana, PA 15701 Phone: 724-465-5576    Fax: 724-465-6379

Dr. Anil Parekh, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 850 Hospital Rd Ste 2200, Indiana, PA 15701 Phone: 724-464-0270    Fax: 724-464-0274

Michael Sauter, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 850 Hospital Rd Ste 2200, Indiana, PA 15701 Phone: 724-464-0270    Fax: 724-464-0273

Aimal Khan, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 793 Old Route 119 Hwy N, Indiana, PA 15701 Phone: 724-465-5576    Fax: 724-465-6379

Dr. Richard Amedeo Cassone, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 850 Hospital Road, Indiana, PA 15701 Phone: 724-464-0270    Fax: 724-464-0274

James A Iannazzi, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 850 Hospital Road, Suite 2200, Indiana, PA 15701 Phone: 724-464-0270    Fax: 724-464-0274

News Archive

Finding potential microRNAs from humans and plants against SARS-CoV-2

A new study focuses on the identification of probable miRNA candidates from three medicinal plants.

Diets that are more climate-friendly are also healthier, finds study

A new Tulane University study examining the carbon footprint of what more than 16,000 Americans eat in a day has good news for environmentally conscious consumers- diets that are more climate-friendly are also healthier.

PKM2 protein controls mitosis, saving cancer cells from death and promoting brain tumor growth

Researchers have caught a protein they previously implicated in a variety of cancer-promoting roles performing a vital function in cell division, survival and development of brain tumors.

Two novel therapies for multiple myeloma

Two novel biologics are currently being investigated for their potential benefit to multiple myeloma patients in separate ongoing clinical trials at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

DPP-4 inhibitors may reduce risk of autoimmune diseases

Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

Read more Medical News

› Verified 3 days ago